OmniAb (OABI) Other Non-Current Assets (2021 - 2026)
OmniAb (OABI) posted quarterly Other Non-Current Assets of $560000.0 for Q1 2026, little changed year-over-year from $560000.0 in Q1 2025, and down 38.6% quarter-over-quarter from $912000.0 in Q4 2025.
OmniAb (OABI) Other Non-Current Assets (2021 - 2026) Analysis & Trends
OmniAb (OABI) has reported Other Non-Current Assets for 6 consecutive years, with $560000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets changed 0.0% year-over-year to $560000.0; the TTM figure through Mar 2026 stood at $560000.0 (changed 0.0% YoY), while the FY2025 annual figure was $912000.0, up 62.86% from the prior year.
- Other Non-Current Assets slipped to $560000.0 in Q1 2026 per OABI's latest filing, from $912000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $3.3 million in Q2 2023 and bottomed at $449000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $1.2 million across 5 years, with a median of $560000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Non-Current Assets plunged 83.26% — and 2025, when it jumped 62.86%.
- OmniAb's Other Non-Current Assets stood at $449000.0 in 2022, then climbed by 24.72% to $560000.0 in 2023, then changed by 0.0% to $560000.0 in 2024, then surged by 62.86% to $912000.0 in 2025, then slumped by 38.6% to $560000.0 in 2026.
- Business Quant data shows OABI's Other Non-Current Assets at $560000.0 in Q1 2026, $912000.0 in Q4 2025, and $560000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 124.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 42.45 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 109.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 18,237.65 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 62.96 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 65.13 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 104.44 Mn |
| 10 | OmniAb | 491.42 Mn | 439.42 Mn | 12.81 Mn | 701,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 701,000.00 |
| Mar 31, 2026 | 560,000.00 |
| Dec 31, 2025 | 912,000.00 |
| Sep 30, 2025 | 560,000.00 |
| Jun 30, 2025 | 560,000.00 |
| Mar 31, 2025 | 560,000.00 |
| Dec 31, 2024 | 560,000.00 |
| Sep 30, 2024 | 1.62 Mn |
| Jun 30, 2024 | 560,000.00 |
| Mar 31, 2024 | 560,000.00 |
| Dec 31, 2023 | 560,000.00 |
| Sep 30, 2023 | 3.19 Mn |
| Jun 30, 2023 | 3.35 Mn |
| Mar 31, 2023 | 3.34 Mn |
| Dec 31, 2022 | 449,000.00 |
| Dec 31, 2021 | 1.50 Mn |